These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 362498)

  • 1. [Effect of hexanicotinate of meso-inositol in patients with primary hyperlipidemia (author's transl)].
    Agusti R; Jordán C; Aste H; Tapia F
    Rev Invest Clin; 1978; 30(4):327-35. PubMed ID: 362498
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of messoinositol hexanicotinate on the treatment of primary hyperlipidemia (author's transl)].
    Ide A; Arteaga A; Maiz A; Ortiz CL; Acosta AM; Fernandez M
    Rev Med Chil; 1976 Nov; 104(11):794-9. PubMed ID: 1021841
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies of the response of normolipemic and dyslipemic aged subjects to 2 forms of delayed-action nicotinic acid polyesters. Pentaerythrotol tetranicotinate and inositol hexanicotinate. Results of a controlled cross-over trial].
    Ziliotto GR; Lamberti G; Wagner A; Cima L; Genco G
    Arch Sci Med (Torino); 1977; 134(4):359-94. PubMed ID: 345998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New drug combination for medical management of hyperlipemia: clinical study].
    Fischer M; Falkensammer C
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
    Stähelin HB; Hartmann G
    Dtsch Med Wochenschr; 1974 Jun; 99(26):1392-4 passim. PubMed ID: 4601124
    [No Abstract]   [Full Text] [Related]  

  • 6. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
    G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inositol hexanicotinate and its cholesteropenic effect].
    Crotte Zamora A; Romo López O
    Prensa Med Mex; 1974; 39(5-6):287-93. PubMed ID: 4612506
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
    Schimert G
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):389-92. PubMed ID: 4208098
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of various types of hyperlipoproteinaemia with a combination of Mg-chlorophenoxy-isobutyrate and mesoinositol-hexanicotinate (author's transl)].
    Bolzano K; Krempler F; Haslauer F
    Arzneimittelforschung; 1979; 29(10):1621-4. PubMed ID: 583231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholestyramine as a cholesterol lowering preparation. A clinical evaluation].
    Bye A; Brox D
    Tidsskr Nor Laegeforen; 1976 Jun; 96(16):928-9. PubMed ID: 779134
    [No Abstract]   [Full Text] [Related]  

  • 11. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 12. [A double-blind clinical trial--the effects of pantethine on serum lipids in patients with hyperlipidemia].
    Lu ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):221-3. PubMed ID: 2697544
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a combination of vasoactive substances on metabolism and the rheoencephalogram].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Wien Klin Wochenschr; 1973 Sep; 123(37):533-8. PubMed ID: 4148002
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)].
    Cucinotta D; Palummeri E; Ceccato S; Passeri M
    G Ital Cardiol; 1977; 7(3):248-64. PubMed ID: 858465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemfibrozil in dyslipidaemia.
    Kundu SC; Roxy S; Batabyal SK
    J Assoc Physicians India; 1990 Feb; 38(2):156-9. PubMed ID: 2199426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ulcers of the lower extremities. Treatment with inositol hexanicotinate].
    Bravo Bernabé PA; Fernández A; Zarraga J; Cruz M; Añorve I
    Prensa Med Mex; 1972; 37(3):151-8. PubMed ID: 4559677
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of pangamic acid (Calgam) in type II hyperlipidemia].
    Bogdañska-Czarnyszewicz ; Czaplicki S; Michajlik A
    Pol Tyg Lek; 1972 Dec; 27(51):2032-5. PubMed ID: 4653721
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study with a new antihyperlipemic combination].
    Pistautz H
    Arzneimittelforschung; 1977; 27(1):152-6. PubMed ID: 576816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of hyperlipidemia. Clinical experience with clinofibrate].
    Avellone G; Di Garbo V; Strano A
    Clin Ter; 1989 Apr; 129(1):25-9. PubMed ID: 2525449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.